HUTCHMED (China) (HMDCF) Income from Continuing Operations (2015 - 2021)
HUTCHMED (China) (HMDCF) reported Income from Continuing Operations of 235697000.0 for Q4 2021, down 203.65% quarter-over-quarter from 77620000.0 in Q2 2021.
HUTCHMED (China) (HMDCF) Income from Continuing Operations (2015 - 2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has 6 years of Income from Continuing Operations data on file, last reported at 235697000.0 in Q4 2021.
- Income from Continuing Operations for Q4 2021 came in at 235697000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was 404560000.0 (changed N/A YoY), and the FY2025 annual result was 64438434.71, up 8132.64% from the prior year.
- Income from Continuing Operations eased to 235697000.0 in Q4 2021 per HMDCF's latest filing, from 77620000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 70120000.0 in Q2 2018 and troughed at 235697000.0 in Q4 2021.
- A 4-year average of 34040153.85 and a median of 30275000.0 in 2020 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2019 and 2021: Income from Continuing Operations jumped 250.63% in 2019, then sank 551.86% in 2021.
- A 4-year view of Income from Continuing Operations shows it stood at 22093000.0 in 2018, then tumbled by 270.87% to 37750000.0 in 2019, then jumped by 145.5% to 17178000.0 in 2020, then sank by 1472.09% to 235697000.0 in 2021.
- Business Quant data shows HMDCF's Income from Continuing Operations at 235697000.0 in Q4 2021, 77620000.0 in Q2 2021, and 60968000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | HUTCHMED (China) | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -235.70 Mn |
| Jun 30, 2021 | -77.62 Mn |
| Mar 31, 2021 | -60.97 Mn |
| Jun 30, 2020 | 17.18 Mn |
| Mar 31, 2020 | -30.28 Mn |
| Dec 31, 2019 | -37.75 Mn |
| Sep 30, 2019 | -34.24 Mn |
| Jun 30, 2019 | -99.44 Mn |
| Mar 31, 2019 | 33.60 Mn |
| Dec 31, 2018 | 22.09 Mn |
| Sep 30, 2018 | 12.78 Mn |
| Jun 30, 2018 | 70.12 Mn |
| Mar 31, 2018 | -22.31 Mn |
| Jun 30, 2016 | 85.09 Mn |
| Jun 30, 2015 | 70.55 Mn |